285 related articles for article (PubMed ID: 16950020)
21. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
[TBL] [Abstract][Full Text] [Related]
22. A review of cervical cancer screening intervention research: implications for public health programs and future research.
Marcus AC; Crane LA
Prev Med; 1998; 27(1):13-31. PubMed ID: 9465350
[TBL] [Abstract][Full Text] [Related]
23. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
Kohl I
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
26. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening: A Slovenian experience.
Primic-Zakelj M; Repse-Fokter A
Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
[TBL] [Abstract][Full Text] [Related]
28. Screening and prevention: cervical cancer.
Weinstein LC; Buchanan EM; Hillson C; Chambers CV
Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
[TBL] [Abstract][Full Text] [Related]
29. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
[TBL] [Abstract][Full Text] [Related]
30. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
[TBL] [Abstract][Full Text] [Related]
31. IR microspectroscopy: potential applications in cervical cancer screening.
Walsh MJ; German MJ; Singh M; Pollock HM; Hammiche A; Kyrgiou M; Stringfellow HF; Paraskevaidis E; Martin-Hirsch PL; Martin FL
Cancer Lett; 2007 Feb; 246(1-2):1-11. PubMed ID: 16713674
[TBL] [Abstract][Full Text] [Related]
32. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
33. New approaches to cervical cancer screening in Latin America and the Caribbean.
Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
[TBL] [Abstract][Full Text] [Related]
34. Cervical and oral cancer screening in India.
Sankaranarayanan R; Dinshaw K; Nene BM; Ramadas K; Esmy PO; Jayant K; Somanathan T; Shastri S
J Med Screen; 2006; 13 Suppl 1():S35-8. PubMed ID: 17227640
[TBL] [Abstract][Full Text] [Related]
35. Re: Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
Gaikwad NL; Mahajan NN; Mahajan KN
Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):258-9; author reply 259. PubMed ID: 17550500
[No Abstract] [Full Text] [Related]
36. Assessing new technologies for cervical cancer screening: beyond sensitivity.
Massad LS
J Low Genit Tract Dis; 2008 Oct; 12(4):311-5. PubMed ID: 18820547
[TBL] [Abstract][Full Text] [Related]
37. [Mass screening programs running in Podlaski region based on standards existing in European Union-- actual status and future perspectives].
Knapp P; Zbroch T; Knapp P; Kobylec M; Błońska E
Przegl Lek; 2004; 61(12):1400-4. PubMed ID: 15850337
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
39. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
